These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15902999)

  • 1. [High-dose buprenorphine substitution during incarceration. Management of opiate addicts].
    Revnaud-Maurupt C; Caer Y; Escaffre N; Gagneau M; Galinier A; Marzo JN; Meroueh F
    Presse Med; 2005 Apr; 34(7):487-90. PubMed ID: 15902999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose buprenorphine substitution during incarceration.].
    Reynaud-Maurupt C; Caer Y; Escaffre N; Gagneau M; Galinier A; Marzo JN; Meroueh F
    Presse Med; 2005 Apr; 34(7):487-490. PubMed ID: 15908859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
    Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
    Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients.
    Riggins DP; Cunningham CO; Ning Y; Fox AD
    Subst Abus; 2017; 38(3):297-302. PubMed ID: 27715904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.
    Gordon MS; Kinlock TW; Schwartz RP; O'Grady KE; Fitzgerald TT; Vocci FJ
    Drug Alcohol Depend; 2017 Mar; 172():34-42. PubMed ID: 28107680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does incarceration influence patients' goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail.
    Vail W; Faro E; Watnick D; Giftos J; Fox AD
    Drug Alcohol Depend; 2021 May; 222():108529. PubMed ID: 33810909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
    Binswanger IA
    N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration.
    Gryczynski J; Lee JD; Dusek K; McDonald R; Sharma A; Malone M; Monico LB; Cheng A; DeVeaugh-Geiss A; Chilcoat HD
    J Subst Abuse Treat; 2021 Aug; 127():108349. PubMed ID: 34134866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is the availability of buprenorphine/naloxone therapy for opioid-dependent inmates a necessity? ].
    Marco A; López-Burgos A; García-Marcos L; Gallego C; Antón JJ; Errasti A
    Rev Esp Sanid Penit; 2013 Feb; 15(3):105-13. PubMed ID: 24270319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: a cross-sectional survey of drug using prisoners.
    Wright NM; Mohammed Z; Hughes GJ
    Drug Alcohol Depend; 2014 Nov; 144():254-8. PubMed ID: 25305714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts].
    Batel P; Reynaud-Maurupt C; Lavignasse P; Constant MV; Kopp P; Jourdain JJ; Videau B; Mucchielli A; Riff B; Lowenstein W
    Presse Med; 2004 Oct; 33(18 Suppl):5-9. PubMed ID: 15617169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.
    Maradiaga JA; Nahvi S; Cunningham CO; Sanchez J; Fox AD
    J Subst Abuse Treat; 2016 Mar; 62():49-54. PubMed ID: 26747509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of opioid maintenance therapy in the community on re-incarceration in individuals with opioid use disorder-A linked cohort study.
    Paola R; Pavel S; Tatiana D; Hagit BN; Joseph M; Ronny B; Barak S
    J Subst Use Addict Treat; 2024 Aug; 163():209393. PubMed ID: 38754555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Dutch national guidelines--pharmacological care for detained opioid addicts.
    Arends MT; De Haan HA; Van 't Hoff GI
    Int J Prison Health; 2009; 5(4):192-200. PubMed ID: 25757520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medically assisted treatment for opiate addiction--suboxone method as prevention of social exclusion of youth--Tuzla model.
    Hasanović M; Pajević I; Kuldija A; Delić A
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S398-404. PubMed ID: 23114824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma.
    Lacroix A; Puybaret V; Villéger P; Zattoni-Leroy J; Cantaloube S; Chevalier C; Nubukpo P
    Therapie; 2024; 79(3):307-317. PubMed ID: 37625937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis].
    Levasseur L; Marzo JN; Ross N; Blatier C
    Ann Med Interne (Paris); 2002 May; 153(3 Suppl):1S14-9. PubMed ID: 12218878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.
    Wang EA; Moore BA; Sullivan LE; Fiellin DA
    J Gen Intern Med; 2010 Jul; 25(7):670-4. PubMed ID: 20213205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.